|
CHD1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.325400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.821600E-01 |
| Normal-vs-Stage2 |
2.571800E-01 |
| Normal-vs-Stage3 |
7.893000E-01 |
| Normal-vs-Stage4 |
6.321000E-01 |
| Stage1-vs-Stage2 |
2.857800E-01 |
| Stage1-vs-Stage3 |
9.405800E-01 |
| Stage1-vs-Stage4 |
7.547000E-01 |
| Stage2-vs-Stage3 |
3.143000E-01 |
| Stage2-vs-Stage4 |
3.554200E-01 |
| Stage3-vs-Stage4 |
8.584200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.330200E-01 |
| Normal-vs-AfricanAmerican |
5.795000E-01 |
| Normal-vs-Asian |
2.070600E-01 |
| Caucasian-vs-AfricanAmerican |
3.139000E-01 |
| Caucasian-vs-Asian |
2.585200E-01 |
| AfricanAmerican-vs-Asian |
8.428300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.173400E-01 |
| Normal-vs-Female |
3.134000E-01 |
| Male-vs-Female |
6.008400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.241800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.833200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.524800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.984000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.263400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.041400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.451000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.363800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.991600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.805400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.501800E-01 |
| Normal-vs-Grade 2 |
9.430400E-01 |
| Normal-vs-Grade 3 |
4.788000E-01 |
| Normal-vs-Grade 4 |
1.739240E-01 |
| Grade 1-vs-Grade 2 |
7.042400E-01 |
| Grade 1-vs-Grade 3 |
9.459400E-01 |
| Grade 1-vs-Grade 4 |
5.114000E-01 |
| Grade 2-vs-Grade 3 |
4.186000E-01 |
| Grade 2-vs-Grade 4 |
1.445620E-01 |
| Grade 3-vs-Grade 4 |
4.848000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.091400E-01 |
| Normal-vs-ccB subtype |
8.711800E-01 |
| ccA subtype-vs-ccB subtype |
4.934400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.572600E-01 |
| Normal-vs-N1 |
4.354200E-01 |
| N0-vs-N1 |
5.362400E-01 |
|
|
